Ikarian Capital’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.92M | Buy |
305,000
+105,000
| +53% | +$3.41M | 1.9% | 9 |
|
|
2025
Q1 | $7.55M | Buy |
+200,000
| New | +$7.55M | 0.93% | 12 |
|
|
2023
Q4 | – | Sell |
-142,417
| Closed | -$7.26M | – | 108 |
|
|
2023
Q3 | $7.26M | Buy |
142,417
+2,417
| +2% | +$123K | 0.87% | 10 |
|
|
2023
Q2 | $6.99M | Sell |
140,000
-85,000
| -38% | -$4.24M | 1.11% | 12 |
|
|
2023
Q1 | $8.43M | Sell |
225,000
-25,000
| -10% | -$937K | 1.91% | 7 |
|
|
2022
Q4 | $12M | Buy |
+250,000
| New | +$12M | 2.89% | 3 |
|
|
2022
Q3 | – | Sell |
-225,991
| Closed | -$4.92M | – | 106 |
|
|
2022
Q2 | $4.92M | Sell |
225,991
-90,000
| -28% | -$1.96M | 0.9% | 16 |
|
|
2022
Q1 | $7.63M | Buy |
315,991
+20,880
| +7% | +$504K | 1% | 9 |
|
|
2021
Q4 | $7.02M | Hold |
295,111
| – | – | 1.05% | 13 |
|
|
2021
Q3 | $7.49M | Sell |
295,111
-152,999
| -34% | -$3.88M | 0.53% | 14 |
|
|
2021
Q2 | $10.1M | Sell |
448,110
-53,000
| -11% | -$1.19M | 0.82% | 13 |
|
|
2021
Q1 | $9.9M | Buy |
501,110
+225,000
| +81% | +$4.44M | 0.33% | 17 |
|
|
2020
Q4 | $7.34M | Buy |
276,110
+260,000
| +1,614% | +$6.91M | 0.32% | 23 |
|
|
2020
Q3 | $796K | Sell |
16,110
-123,703
| -88% | -$6.11M | 0.06% | 73 |
|
|
2020
Q2 | $4.42M | Buy |
+139,813
| New | +$4.42M | 0.35% | 27 |
|